{
  "id": "cluster_9_doc2",
  "content": "Patient TK4721 (DOB 09/18/1985) was admitted to Mesa Ridge Proton Center on 03/12/2024 with recurrent chordoma. Treatment plan included 28 proton therapy sessions combined with investigational drug NVX-207. Genetic testing revealed FGFR2 mutation. Insurance coordinator Miriam Reyes noted complications with CRS-229M policy updates delaying treatment start by 11 days.",
  "metadata": {
    "format": "medical_record"
  }
}